| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/10/2011 | WO2011016436A1 Method for producing freeze-dried composition containing fine polylactic acid particles |
| 02/10/2011 | WO2011016435A1 Method for producing freeze-dried composition containing polylactic acid particles |
| 02/10/2011 | WO2011016144A1 Composite pigment and method for preparation thereof |
| 02/10/2011 | WO2011016143A1 Composite pigment and method for preparation thereof |
| 02/10/2011 | WO2011016057A2 Controlled release pharmaceutical compositions of milnacipran |
| 02/10/2011 | WO2011016049A2 A stable composition of ready-to-use gemcitabine injection |
| 02/10/2011 | WO2011016043A2 Antibiotic drug delivery and potentiation |
| 02/10/2011 | WO2011015964A1 Controlled-release granular compositions containing mesalazine and process for the manufacture thereof |
| 02/10/2011 | WO2011015226A1 Process for the preparation of sterile powdered pharmaceutical compounds in the form of micro and nanoparticles |
| 02/10/2011 | WO2011014960A1 Process for preparation of over-the-counter gelatin or pectin-based drug delivery |
| 02/10/2011 | WO2011014925A1 Process for obtaining peptide fractions |
| 02/10/2011 | WO2010146575A3 Solid forms for tissue repair |
| 02/10/2011 | WO2010124837A3 Encapsulated liver cell composition |
| 02/10/2011 | WO2010124280A3 Human serum albumin-based topical ointment for treatment of acne, psoriasis, egfr-induced toxicity, premature skin aging and other skin conditions |
| 02/10/2011 | US20110035023 Prosthesis for promoting the in vivo reconstruction of a hollow organ or a portion of a hollow organ |
| 02/10/2011 | US20110034926 Bioresorbable material |
| 02/10/2011 | US20110034916 Nanoparticle-mediated microwave treatment methods |
| 02/10/2011 | US20110034909 Safety limits for closed-loop infusion pump control |
| 02/10/2011 | US20110034867 Microthread delivery system |
| 02/10/2011 | US20110034857 Implantable Fluid Delivery Apparatuses and Implantable Electrode |
| 02/10/2011 | US20110034854 Pdt assisted vision correction and scar prevention |
| 02/10/2011 | US20110034685 Method for Purification of Lactose |
| 02/10/2011 | US20110034568 Compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 02/10/2011 | US20110034566 Long term drug delivery devices with polyurethane based polymers and their manufacture |
| 02/10/2011 | US20110034550 Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same |
| 02/10/2011 | US20110034518 Pharmaceutical composition |
| 02/10/2011 | US20110034430 Phospholipid Gel Compositions for Drug Delivery and Methods of Treating Conditions Using Same |
| 02/10/2011 | US20110033553 Embolization |
| 02/10/2011 | US20110033552 Apatite/collagen composite powder, formable-to-any-shape artificial bone paste, and their production methods |
| 02/10/2011 | US20110033551 Nucleic acid microspheres, production and delivery thereof |
| 02/10/2011 | US20110033550 Nanoparticle carriers for drug administration and process for producing same |
| 02/10/2011 | US20110033549 Stabilisation of Proteins |
| 02/10/2011 | US20110033548 Degradable crosslinked aminated dextran microspheres and methods of use |
| 02/10/2011 | US20110033547 Dehydrated chitosan nanoparticles |
| 02/10/2011 | US20110033546 Pure sustained dichroa ferbrifuga alkone formulation |
| 02/10/2011 | US20110033545 Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith |
| 02/10/2011 | US20110033544 Intranasal pharmaceutical compositions with improved pharmacokinetcs |
| 02/10/2011 | US20110033543 Hydrogels with covalent and noncovalent crosslinks |
| 02/10/2011 | US20110033542 Sublingual and buccal film compositions |
| 02/10/2011 | US20110033541 Sublingual and buccal film compositions |
| 02/10/2011 | US20110033540 Polymer formulations for delivery of bioactive agents |
| 02/10/2011 | US20110033539 Compositions and methods for preparing and using same |
| 02/10/2011 | US20110033538 Pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof |
| 02/10/2011 | US20110033537 Sustained Drug Release Composition |
| 02/10/2011 | US20110033536 24-hour sustained-release metoclopramide |
| 02/10/2011 | US20110033535 Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
| 02/10/2011 | US20110033534 Controlled release tamsulosin hydrochloride tablets and a process of making them |
| 02/10/2011 | US20110033533 Galenical formulations of organic compounds |
| 02/10/2011 | US20110033532 Aqueous polymer dispersion based on n,n-diethylaminoethyl methacrylate, its preparation and use |
| 02/10/2011 | US20110033531 Second Generation Fatty Acid Compositions, Formulations, and Methods of Use and Synthesis Thereof |
| 02/10/2011 | US20110033530 Coating composition for the dip coating of capsule halves |
| 02/10/2011 | US20110033529 Oral pharmaceutical paricalcitol formulations |
| 02/10/2011 | US20110033528 Stabilized picoplatin oral dosage form |
| 02/10/2011 | US20110033527 Opthalmic compositions of cyclosporin |
| 02/10/2011 | US20110033526 Pharmaceutical composition of antibiotics and prebiotics for preventing and treating dysbiosis during antibacterial therapy |
| 02/10/2011 | US20110033525 Diterpene Glycosides as Natural Solubilizers |
| 02/10/2011 | US20110033524 Treatment of tumors |
| 02/10/2011 | US20110033523 Use of microvesicles (mvs) derived from stem cells for preparing a medicament for endo/epithellal regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods |
| 02/10/2011 | US20110033522 Reagents for inducing an immune response |
| 02/10/2011 | US20110033521 Molecules and Methods of Using Same for Treating MCP-1/CCR2 Associated Diseases |
| 02/10/2011 | US20110033520 Antimicrobial Nanostructured Hydrogel Web Containing Silver |
| 02/10/2011 | US20110033518 Peptides promoting lipid efflux via abca1 and activating a lipoprotein lipase |
| 02/10/2011 | US20110033516 Methods and compositions for bone healing by periostin |
| 02/10/2011 | US20110033515 Tissue contacting material |
| 02/10/2011 | US20110033512 Personal care composition with improved spreadability |
| 02/10/2011 | US20110033508 Injectable microspheres for dermal augmentation and tissue bulking |
| 02/10/2011 | US20110033507 Polypeptides KXK and Their Use |
| 02/10/2011 | US20110033506 Combination dosage form of low-dose modafinil and low-dose sildenafil |
| 02/10/2011 | US20110033505 Methods and compositions for treatment of ion imbalances |
| 02/10/2011 | US20110033504 Articles and methods for repairing damaged nervous tissue |
| 02/10/2011 | US20110033503 Dressing compositions and methods |
| 02/10/2011 | US20110033392 Deodorizing composition under weak acidity |
| 02/10/2011 | US20110033391 Transferases and Oxidoreductases, Nucleic Acids Encoding them and methods for making and using them |
| 02/10/2011 | DE102009036767A1 Kompositpartikel für den Einsatz in der Mundhygiene Composite for use in oral hygiene |
| 02/10/2011 | CA2805127A1 Process for preparation of over-the-counter gelatin or pectin-based drug delivery |
| 02/10/2011 | CA2775091A1 Controlled release pharmaceutical compositions of milnacipran |
| 02/10/2011 | CA2771089A1 Sublingual and buccal film compositions |
| 02/10/2011 | CA2770180A1 Sublingual and buccal film compositions |
| 02/10/2011 | CA2770149A1 Controlled release formulations of lipocalin muteins |
| 02/10/2011 | CA2770077A1 Formulations comprising linaclotide |
| 02/10/2011 | CA2769323A1 Nutritional compositions comprising fiber and probiotics |
| 02/10/2011 | CA2769221A1 Concentrated polypeptide formulations with reduced viscosity |
| 02/10/2011 | CA2768425A1 Controlled-release granular compositions containing mesalazine and process for the manufacture thereof |
| 02/09/2011 | EP2281576A1 Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition |
| 02/09/2011 | EP2281572A1 West Nile Vaccine |
| 02/09/2011 | EP2281567A1 Inhibitor for blood phosphorus level elevation |
| 02/09/2011 | EP2281560A1 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucomatous optic neuropathy |
| 02/09/2011 | EP2281559A1 Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis |
| 02/09/2011 | EP2281557A2 Pharmaceutical formulation containing angiotensin-ii receptor blocker |
| 02/09/2011 | EP2281556A1 Tablets with improved drugs substance dispersibility |
| 02/09/2011 | EP2281555A2 Once-a-day oxycodone formulations |
| 02/09/2011 | EP2281554A1 Eye drop composition comprising ketotifen |
| 02/09/2011 | EP2281553A2 Pharmaceutical composition and method for treating hypogonadism |
| 02/09/2011 | EP2280712A2 Fluocinolone formulations in a biodegradable polymer carrier |
| 02/09/2011 | EP2280694A1 Humidity-resistant drug formulations and methods of preparation thereof |
| 02/09/2011 | EP2280693A2 Liquid and freeze dried formulations |
| 02/09/2011 | EP2280692A1 Tablet comprising eprosartan mesylate |
| 02/09/2011 | EP2280691A1 Stable crystal modifications of dopc |
| 02/09/2011 | EP2280690A2 Methods for treating herpes virus infections |
| 02/09/2011 | EP2280689A1 Stable ophthalmic formulations |